Carl Smith Email & Phone Number

East Hanover, New Jersey, United States

I transition from Novartis Gene Therapies having spent ~ 3 years working with an exceptional team to deliver life-saving treatments for patients with rare and debilitating disease. I am excited to join a strong marketing and cross-functional team in US Oncology and look forward to re-imagining medicine together. #novartisgenetherapies #novartisoncology

Lead global brand strategy, planning and promotion for gene therapies that treat rare and debilitating diseases.

Bannockburn Illinois

Lead brand strategy and messaging, HCP promotional planning, competitive intelligence, launch readiness, global cross-functional team leadership

Indianapolis, Indiana Area

Resonsible for Marketing and launch excellence across the enterprise. This includes customer, market understanding, deep patient insights (captured through patient journeys), brand strategy (positioning, segmentation, brand campaigns) proficiency in digital, multi-channel-engagement (right customer, right content, right channel/engagement, right time) use of data and analytics and launch excellence.These capabilities are enabled through development of consistent frameworks, nomenclature, standards and tools which are deployed through live consultation (internal consulting) with brand teams, formal training and rotational programs to facilitate on-the-job learning to drive commercial success and world class launch uptake

Indianapolis Usa

Served as a “player-coach” leading a small team, with commercialization responsibility for a portfolio of brands (~$900 million in revenue) across the Emerging Markets Business Unit with focus on Mexico, Brazil, China, Korea, Turkey, Russia, Africa and South East Asia.Reported directly to the VP of Marketing, Emerging Markets and was responsible for the performance turn-around of Lilly’s largest Emerging Market brand, which delivered volume, revenue and market share growth and surpassed sales plan, for two consecutive years following a period of flat and under-plan performance➠ Responsibilities include P & L oversight, brand planning, commercial strategy, life-cycle management/post patent strategy, marketing capabilities with a priority focus on improving customer value results from our key customer groups

United Kingdom

As Chief Marketing Officer and Specialty Business Unit Director, UK and Ireland, I was responsible for leading a team of Marketers to develop launch and commercialization strategies across the UK business. Held direct P&L responsibility for the specialty business unit and oversaw Marketing for in-line and launch brands. This included Marketing capability development, Customer Experience and launch uptake. Served as a member of the UK/ROI lead team reporting to the Managing Director.➠ Key accomplishment was launch of a new indication/line extension for one of Lilly's major brands.➠ Other areas of impact included the re-acceleration of performance of a key brand through a series of buy-up’s/investments in new indication/line extension (diabetic peripheral neuropathic pain).➠Drove a marketing capability agenda to advance the practice of Marketing across the affiliate.

Lead the commercialization efforts for the Neuroscience Portfolio in the Emerging Markets Business Unit. Therapeutic areas include: Schizophrenia, Bipolar Disorder, Depression & Attention Deficit Hyperactivity Disorder. Key Markets: China, Korea, Turkey, Russia, Mexico & Brazil. Key Responsibilities:➠ Player / coach role including 2 direct reports➠ Serve as Key Advisor to affiliate brand teams ➠ Review and approve complicated affiliate brand plans➠ Support affiliate marketing directors in developing marketing capabilities of their local marketers➠ Responsible for development & roll out of Marketing Strategy within the Emerging Markets BU➠ Oversee development & implementation of regional marketing programs within the region.

Global Strategy / Regional Brand Leader - Intercontinental Region & Japan (ICR)Geography: Intern-continental Region (ICR) - Canada, Asia including Japan & China, Australia/New Zealand, South America, Africa Middle East Area. Responsibilities include: ➠ Responsibility & accountability for Global brand plan & planning process including Global strategy.➠ Single point of contact with affiliates in the Intercontinental Region. Provide a consultant function through affiliate coaching, brand plan reviews, brand development, implementation workshops, best practices sharing & cross-functional collaboration.➠ Performance updates & reviews with senior leadership at corporate level summarising performance trends & key focus areas.

Central & Eastern Europe, Africa Middle East Area, Commonwealth of Independant States (AMEA-CEE-CIS)Drive marketing competency with neuroscience brand mangers across the region & reinforce brand strategy through 1:1 contacts & quarterly teleconferences with affiliate brand mangers. Review & provide feedback on affiliate neuroscience brand plans. Role model cross-functional collaboration. Delivery of lead detail aids for neuroscience across the region. Delivery of greater process efficiency & improved customer centricity through institutionalization of e-initiatives, best practice sharing & centralised promotional material.

Led the South African launch effort of Cymbalta resulting in the most successful market share uptake worldwide. Worked with the cross-functional team in South Africa to rectify the declining sales trend of Zyprexa resulting in a turnaround in brand equity & performance.

Region: Johannesburg South AfricaProducts include: Mens Health, Depression, Womens Health & Diabetes.Reports: Total of 10 sales representative spanning retail & speciality divisions.

Advanced Marketing Capabilities Program, Business Administration And Management, General

Grateful to participate in the Wharton Advanced Marketing Capability program sponsored by Novartis.

B.Tech Marketing & Sales, Commerce & Governmental Studies

Activities and Societies: Institute of Marketing Management Committee Member Nelson Mandela University Alumni Rectors award 1998.